-
Benzinga’s Top Pre-Market Losers (MDVN, VISN, CMED, CPNO)
Wednesday, March 3, 2010 - 9:33am | 267Medivation, Inc. (NASDAQ: MDVN) decreased 69.81% to $12.15 in the pre-market session after Pfizer (NYSE: PFE) and Medivation announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine) in patients with Alzheimer's disease. MDVN has gained over 60% in the last six...
-
Top PIIGS Stocks
Wednesday, March 3, 2010 - 3:05am | 769The 'PIGGS' are the European countries that are suffering due to current economic woes. The countries are Portugal, Italy, Ireland, Greece, and Spain, and the crises that is looming is heavy. Recently, there has been much talk about Greece being bailed out by stronger EU countries, but even that is...
-
Crazy Biotech Bid Ups
Tuesday, March 2, 2010 - 6:26pm | 478One of the more common methods of volatility analysis used by option traders is that of comparing historical volatility to implied volatility. The efficacy of this approach hinges on whether or not the past can be a good predictor of the future. In other words, can a stock's price behavior...
-
Benzinga’s Top Downgrades (MU, RDC, MIL, SUG, RISK)
Tuesday, March 2, 2010 - 2:49pm | 267Micron Technology Inc (NASDAQ: MU) was downgraded by UBS from “buy” to “neutral.” MU has a 52-week trading range of $2.55-$11.34. MU’s shares lost 1.38% to $9.64 by 11:39 am. Read more about this company here. MKM Partners downgraded Rowan Companies Inc (NYSE: RDC) from “buy” to “neutral.” RDC’s...
-
Sequenom (SQNM) Jumps 22% on Analyst Upgrade
Tuesday, March 2, 2010 - 2:22pm | 760Our old buddy Sequenom (SQNM) has been surging the last week, as analysts are enjoying the story management is telling them. Along with momo daytraders jumping in I am sure. I am not sure how you value a company which no longer has verifiable results but I'd assume 90% of the people in the stock...
-
Sequenom Inc. (SQNM) May Now Face Resistance At A Higher Level Of $12
Tuesday, March 2, 2010 - 2:09pm | 103Sequenom Inc. (NASDAQ: SQNM) surged 20% to $8.22, after rising to even higher levels earlier on Tuesday morning. The biotechnology company Sequenom Inc. (SQNM) was upgraded to “buy” from “hold” by Cantor Fitzgerald & Co. and to “hold” from “sell” at Hapoalim Securities. The gap-up opening...
-
Sequenom Squeezes the Shorts
Tuesday, March 2, 2010 - 11:25am | 116Sequenom (NASDAQ: SQNM) is shooting higher this morning by over 16%. There does not appear to be any significant news coming out of the stock except for an upgrade to “Buy” from “Hold” over at Cantor Fitzgerald. The stock was also upgraded to “Hold” from “Sell” at Hapoalim Securities yesterday....
-
Karen Finerman Thinks There Might Be Other Bidders For MIL
Monday, March 1, 2010 - 7:01pm | 163Karen Finerman said on CNBC's Fast Money that she sold half of her position in Millipore Corporation (NYSE: MIL). She added that she should have sold her entire position, but she believes that there might be some other buyers out there for this company. Millipore (MIL) jumped 11.11% as Merck...
-
M&A Activity Drives Stocks Up On Wall Street
Monday, March 1, 2010 - 4:32pm | 175Sudden M&A activities moved U.S. stocks higher on Monday morning, helped along by stronger-than-expected consumer spending and signs that a Greek bail-out may be imminent. American International Group Inc. (NYSE: AIG) rose 9.3% to $27.07 after Prudential (NYSE: PRU) agreed to buy its Asian...
-
Merck KGaA To Acquire Millipore For About $6 Billion (MIL)
Monday, March 1, 2010 - 3:48pm | 256Merck KGaA (ADR) (OTC: MKGAY), the Germany based drug company, agreed to buy Millipore Corp. (NYSE: MIL), a life science company, for about $6 billion. Millipore is valued at $107 per share, which is 13 percent higher than the company’s closing price on Feb 26. According to Merck spokeswoman...
-
Limited Risk Trade in AMAG
Monday, March 1, 2010 - 1:08pm | 118Biopharmaceutical company AMAG Pharmaceuticals (NASDAQ: AMAG) is selling off by nearly 7.00% this morning following a lackluster earnings report from the company. The company reported a net loss of $1.07 per share on $13.1 million in revenue. The company is receiving a large, limited risk trade...
-
AMAG Pharmaceuticals (AMAG) Shares Fall Nearly 7%
Monday, March 1, 2010 - 12:21pm | 89Shares of AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) tumbled 6% during morning trading after the company produced financial results that failed to impress Wall Street. The bio-pharmaceutical company reported a net loss of $18.4 million, or $1.07 per share, versus a net loss of $21.8 million, or $1....
-
Leerink Swann Suspends Millipore (MIL) Rating After Acquisition Announced
Monday, March 1, 2010 - 9:18am | 121Leerink Swann analysts Isaac Ro and Jeff Ares suspended their rating of Millipore Corporation (NYSE: MIL) due to the pending acquisition of the company by Germany's Merck KGaA. The analysts said that they would, "no longer put forth a valuation on MIL shares as our rating is suspended due to the...
-
Bruker Corporation (BRKR) Maintains A Hold Rating
Friday, February 26, 2010 - 11:05pm | 115Analyst Jon Wood at Jefferies & Company, Inc. has maintained a Hold rating for Bruker Corporation (NASDAQ: BRKR). The company reported GAAP EPS of $0.26 for the fourth-quarter, ahead of the consensus estimate of $0.22. The upside to earnings was mainly due to stronger revenue growth, and...
-
ICON (ICLR) Maintains A Buy Rating
Friday, February 26, 2010 - 9:58pm | 97Analyst David Windley at Jefferies & Company, Inc. has maintained a Buy rating for ICON plc (ADR) (NASDAQ: ICLR). Jefferies has maintained its price target of $28.50 for ICON plc. The company has reported results for the fourth-quarter. The company reported EPS of $0.40 on revenue of $227...